• 10Feb

    Vitrification by definition, according to Wikipedia is the process of converting a substance into a glass, however this does not properly explain what the process of vitrification helps with in assisting in fertility methods be it IVF, ICSI or IUI.

    Why Vitrification?

    The main problem when freezing cells is the formation of intracellular ice crystals during both cooling and warming, since these ice crystals have detrimental effect on cell survival. Vitrification, the extremely rapid freezing of cellular materials, makes it possible to freeze cells without forming ice crystals within the cells. The result of vitrification is a very homogenous, amorphous crystalline structure.

    Why Nidacon Vitrification?

    Vitriblast and Thermoblast are based on clinically, well tested standard formulations (lane et al). Numerous publications demonstrate their effectiveness regarding both survival of blastocysts and pregnancy rates.

    Follow-up studies have been done on live-births, where a comparison was made with babies from fresh blastocysts, slow-frozen early cleavage stage embryos and vitrified blastocysts.

    Since the formulisations have been used considerably, Nidacon can provide you with a very detailed protocol for vitrifying blastocysts, just for your security.

    KAT Laboratory is a distributor of the Nidacon Products in South Africa

    For more information on Nidacon products please

    Contact us on 0027 11 472 7300 / sales@katmedical.com

    www.katmedical.com

    Posted via email from katmedical’s posterous

  • 09Feb

    Why is Blood grouping important?

    A person’s blood type becomes a crucial matter when a blood transfusion is necessary. If an individual is transfused with the wrong blood type, a reaction that severely compromises the immune system can result. There are different levels at which a mismatched transfusion can occur, from minor to major incompatibility. Minor factors may lead to very minor problems, but a major incompatibility of blood type during a transfusion can be serious.

    Blood type is so important during a transfusion that donors giving blood to a blood bank must meet certain requirements. A blood transfusion is closely monitored, often by a haematologist.

    In pregnancy…

    Blood tests will check your blood type, your Rh status, and an antibody screen. Your blood type needs to be checked so that a potential mix-up of bloods can be averted if there is a need for a transfusion. Rh negative women need to be identified in advance so that they can be considered as candidates for RhoGAM, an immunoglobulin that is given at 28 weeks of pregnancy and within 72 hours of delivery in order for the mother to keep from becoming Rh sensitized. Occasionally, RhoGAM is also given when there is a potential risk for fetal blood to mix with the mother’s blood, such as in a car accident or in amniocentesis.Why it’s important (RhoGAM): Giving this medication prevents the mother’s body from mounting an antibody response against an Rh positive baby in future pregnancies. An antibody screen detects antibodies, both Rh and less common types, that may occur in the fetus or newborn.

    Why it’s important (antibody screen): Antibodies have the potential for causing blood disease in the fetus and newborn.

    In the case of organ transplants, the tissue of the donor organ must match the recipient’s blood type. A mismatch can cause rejection, and therefore, without a positive match, the transplant will not be conducted. Individuals placed on a transplant waiting list have their blood type thoroughly tested before being placed on the list.

    What are the different blood groups?

    In 1901, scientist Karl Landsteiner reported that blood could be classified into blood ‘types’.

    There are 4 main blood groups A, B, AB and O, of which group O is the most common (47% of population). The blood type is determined by proteins called antigens found on the surface of red blood cells. If you have the antigen A on the red blood cells then you have got type A blood. When B antigen is present, you have type B blood, when both A and B are present, you have type AB blood. When neither are present you have type O blood.

    Another blood group system involves Rhesus factors. The name Rhesus comes from the Rhesus monkeys in which the protein was first discovered. Rhesus factor D, the most important, is found in the blood of 85% of people, they are known as Rhesus positive. The remaining 15% are Rhesus negative. So people can be classified according to both systems, for example AB positive or O negative.

    The Rhesus factor is important during pregnancy, a baby’s life can be endangered if it inherits a Rhesus positive blood type from its father while the mother is Rhesus negative. This is because the mother can form antibodies against the baby’s blood.

    Here is a list of the blood types and their frequency in the general population :

    O Rh (D) Positive 40%
    O Rh (D) Negative 7%
    A Rh (D) Positive 36%
    A Rh (D) Negative 6%
    B Rh (D) Positive 7%
    B Rh (D) Negative 1%
    AB Rh (D) Positive 2.5%
    AB Rh (D) Negative 0.5%

    Eldon card Blood grouping test procedure…

    Step 1

    Place one drop of water in each field with a pipette. DO NOT LET THE WATER DRY.

    Step 2

    Disinfect a finger. Let the finger dry. With a lancet make a small puncture.

    Step 3

    Collect one drop of blood for each field on an ELDONstick®. Use a new ELDONstick® for each field.

    Step 4

    Blood drops should fit the base of the ELDONstick®.

    Step 5

    Place the blood drops into the fields of your ELDONCARD®. Keep the stick in contact with the card.

    Step 6

    Mix blood and reagent with a rotating movement for approx. 15 seconds. Spread mixture to the perimeter of the circles.

    Step 7

    Tilt the ELDONCARD® to a vertical position. After 10 seconds tilt the ELDONCARD® 180° to allow blood to travel across the reaction fields. Wait 10 seconds. Tilt the ELDONCARD® 90° to the left – wait 10 seconds. Tilt the ELDONCARD® 180° to the right – wait 10 seconds. Read and record the result. Let the ELDONCARD® dry (approx. 2 minutes if you use a hairdryer).

    Step 8

    Cover the agglutinations with adhesive foil to prevent deterioration of reactions and to seal possible infectious material.

    KAT Laboratory is a distributor of the eldon card system in Southern Africa

    For more information on the Eldon Card Blood grouping please

    Contact us on 0027 11 472 7300 or sales@katmedical.com

    www.katmedical.com

    Posted via email from katmedical’s posterous

    Tags: , , ,

  • 02May

    Pasteur Institute of Madagascar

    Standard Diagnostics

    Standard Diagnostics

    Mycobacterium Unity
    Intermediary Report (11/07/2008)
    Evaluation of the SD TB Ag MPT64 kit
    I. Context
    The biological, immunological and molecular characterizations of Mycobacterium Tuberculosis lead to the identification of different antigens useful for the elaboration of better diagnosis methods in order to make the distinction between tuberculosis complex, responsible for tuberculosis, and other mycobacterium not belonging to this complex.
    MPT64 is one of the predominant proteins secreted by Mycobacterium Tuberculosis. This protein is secreted during active growing of strains of tuberculosis complex. It is an immunogenic protein of 24 kDa specific to tuberculosis complex. This antigen has been suggested as potential candidate of a vaccine composition because it is preferentially recognized by Tcells CD4+.
    II. Problem of the research and objectives
    Recently, Standard Diagnostics, Inc. has developed an easy and rapid method using mouse monoclonal antibodies anti-MPT64. The kit can be easily used in laboratories for a rapid identification of tuberculosis bacilli from solid or liquid culture.
    The principal objective of this study is to evaluate the ‘SD TB Ag MPT64 Rapid test’ for identification of Mycobacterium of tuberculosis complex.
    More specifically, this study is done to;
    -
    evaluate performances of the test for identification of tuberculosis bacillus isolates from solid culture (Lowenstein Jensen medium)
    -
    Compare results of the new test with results of classical tests for identification of mycobacterium (biochemical tests) used in laboratory.
    III. Methodological and experimental approach
    The study was done on strains of the Laboratory of Mycobacterium of the Pasteur Institute of Madagascar. These strains contained mycobacterium of tuberculosis complex (M. Tuberculosis and M. Bovis) and other atypical mycobacterium. Other bacterial species were tested to evaluate the specificity of the new test. These species were collected from the Clinical Biology Center of the Pasteur Institute of Madagascar.
    A first evaluation is done on 81 strains (all species mixed). The second step of the evaluation will be done with other strains according to the number of tests available (88 tests).
    For the first step, strains of M. Tuberculosis , M. Bovis , atypical mycobacterium and other non-mycobacterium pathogen strains have been selected to be tested with the kit:
    For each strain, SD Ag MPT64 has been tested in parallel with specific identification of each strain.
    The results of the identification of mycobacterium of tuberculosis complex were compared to biochemical identification results.
    During manipulations, the reference strain H37 Rv (mycobacterium laboratory-IPM) was used as positive sample and distilled water as negative sample.
    Table: Repartition of strains used
    Strain
    Number
    M. Tuberculosis
    36
    M. Bovis
    12
    Atypical Mycobacterium
    13
    other non-mycobacterium pathogen strains
    20
    IV. Results
    ????
    From 02 to 09 July 2008, the kit has been evaluated on:
    -
    36 strains of M. Tuberculosis
    -
    12 strains of M. Bovis
    -
    13 strains of Atypical Mycobacterium
    -
    20 strains of other non-mycobacterium pathogen strains
    ????
    Biochemical identification
    The identification of the mycobacterium strains is done following the algorithm of the Mycobacterium Laboratory based on an assembly of morphologic, cultural and biochemical criteria. The specific identification of the other pathogen bacteria is done following the algorithm of the Biological Institute of Madagascar.
    ????
    Identification by SD Ag TB MPT64
    For each strain a sample of the colony on the solid culture is taken and diluted in an Eppendorf containing 200 ?l of extraction buffer included in the kit. After strong vortexing, 100 ?l of this mix is taken and add on the device. If two lines (Test (T) and Control (C)) in the window, the result is positive. If one single line appears on the Control line, the test is negative. The results have been interpreted in double-blind.
    The results obtained with SD TB Ag MPT64 were concordant with the results of the biochemical identification. All the samples of the non tuberculosis complex gave a negative result with the kit.
    ????
    Result analysis
    In total 48 strains of tuberculosis complex and 33 non-tuberculosis strains have been tested by the SD Ag MPT64 kit.

    Sensibility = 48 / (48+0) = 1 ie 100%
    Specificity = 33/33 = 1 ie 100%
    PPV=48 / (48+0) = 1 ie 100%
    NPV= 33/(3+0)3 = 1 ie 100%
    Remark: Two strains in collection identified as M. Bovis (01-3236) and M. mucogenicum gave respectively a negative and positive result with TB Ag MPT64 test. The parallel biochemical identification of these strains showed that the first strain was an atypical mycobacterium and the second one was a M.Tuberculosis strain.
    Conclusion
    According to the results of this first evaluation, SD TB Ag MPT64 presents a good sensibility (100%) and a good specificity (100%) to identify mycobacterium of the tuberculosis complex (M.Tuberculosis and M. Bovis). The evaluation of the kit will be continued on a prospective manner in the Laboratory of Mycobacterium in parallel with biochemical identification of the strains.

   

Get Adobe Flash playerPlugin by wpburn.com wordpress themes